The potential of lemon balm (Melissa officinalis L.) essential oil as an anti-anxiety agent - is the citronellal the activity carrier?
暂无分享,去创建一个
[1] Tadaaki Satou,et al. Effects of Inhalation of Essential Oil From Pelargonium graveolens on the Autonomic Nervous System of Awake Mice , 2022, Natural Product Communications.
[2] M. Howes,et al. New Insights Into the Anticonvulsant Effects of Essential Oil From Melissa officinalis L. (Lemon Balm) , 2021, Frontiers in Pharmacology.
[3] Pavle J. Randjelović,et al. Lemon balm (Melissa officinalis L.) essential oil and citronellal modulate anxiety-related symptoms - In vitro and in vivo studies. , 2021, Journal of ethnopharmacology.
[4] M. Mirghafourvand,et al. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta‐analysis , 2021, Phytotherapy research : PTR.
[5] G. Di Giovanni,et al. Effects of Different Anxiety Levels on the Behavioral Patternings Investigated through T-pattern Analysis in Wistar Rats Tested in the Hole-Board Apparatus , 2021, Brain sciences.
[6] J. Simal-Gándara,et al. Minerals, Essential Oils, and Biological Properties of Melissa officinalis L. , 2021, Plants.
[7] S. Sadigh-Eteghad,et al. Melissa officinalis L. hydro‐alcoholic extract inhibits anxiety and depression through prevention of central oxidative stress and apoptosis , 2020, Experimental physiology.
[8] I. Ilić,et al. Toxic essential oils, part VI: Acute oral toxicity of lemon balm (Melissa officinalis L.) essential oil in BALB/c mice. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[9] S. Malami,et al. Anxiolytic-Like Effect of Methanol Leaf Extract of Laggera aurita Linn. F. (Asteraceae) in Mice , 2018 .
[10] Pavle J. Randjelović,et al. Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: A cross-sectional study , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[11] Murray B Stein,et al. Anxiety , 2017, The Lancet.
[12] A. Sahebkar,et al. Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. , 2016, Journal of ethnopharmacology.
[13] B. Bandelow,et al. Epidemiology of anxiety disorders in the 21st century , 2015, Dialogues in clinical neuroscience.
[14] A. Atanasov,et al. Ethnopharmacological in vitro studies on Austria's folk medicine—An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs , 2013, Journal of ethnopharmacology.
[15] G. Thornicroft,et al. Mental illness stigma, help seeking, and public health programs. , 2013, American journal of public health.
[16] D. Silveira,et al. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender , 2012, Indian journal of pharmacology.
[17] N. Singewald,et al. The clinical implications of mouse models of enhanced anxiety. , 2011, Future neurology.
[18] J. Lépine,et al. The increasing burden of depression , 2011, Neuropsychiatric disease and treatment.
[19] D. Béracochéa,et al. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[20] A. Jäger,et al. Neuroprotective and Neurological Properties of Melissa officinalis , 2009, Neurochemical Research.
[21] E. Perry,et al. Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti‐agitation properties: focus on ligand‐gated channels , 2009, The Journal of pharmacy and pharmacology.
[22] D. Baldwin. Room for improvement in the pharmacological treatment of anxiety disorders. , 2008, Current pharmaceutical design.
[23] Gillian R Brown,et al. The exploratory behaviour of rats in the hole-board apparatus: Is head-dipping a valid measure of neophilia? , 2008, Behavioural Processes.
[24] D. Baldwin,et al. Generalised anxiety disorder , 2006, The Lancet.
[25] C. DeVane,et al. Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. , 2005, The American journal of managed care.
[26] E. Basch,et al. Catherine Ulbricht, PharmD, MBA(C), Column Editor Lemon Balm (Melissa officinalis L.) , 2005 .
[27] P. Alves,et al. Melissa officinalis L. essential oil: antitumoral and antioxidant activities , 2004, The Journal of pharmacy and pharmacology.
[28] Dan J Stein,et al. Animal models of anxiety disorders , 2003, Current psychiatry reports.
[29] M. Hascöet,et al. A New Approach to the Light/Dark Test Procedure in Mice , 1998, Pharmacology Biochemistry and Behavior.
[30] Y. Ichimaru,et al. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. , 1995, Japanese journal of pharmacology.
[31] C. Belzung,et al. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety , 1994, Physiology & Behavior.
[32] S. Handley,et al. Evaluation of marble-burying behavior as a model of anxiety , 1991, Pharmacology Biochemistry and Behavior.
[33] D. Treit. Animal models for the study of anti-anxiety agents: A review , 1985, Neuroscience & Biobehavioral Reviews.
[34] E. O. Alvarez,et al. Further evidence that histamine in hippocampus affects the exploratory behavior in the rat , 1985, Physiology & Behavior.
[35] F. Goodwin,et al. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines , 1980, Pharmacology Biochemistry and Behavior.
[36] B. S,et al. Pharmacogenomic assessment of herbal drugs in affective disorders. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.